Filtered By:
Condition: Migraine
Vaccination: Shingles (Herpes Zoster) Vaccine
This page shows you your search results in order of date.
Order by Relevance | Date
Total 35 results found since Jan 2013.
Reactivation of Herpes Zoster After Recombinant Vaccine (Shingrix): A Case Report
We describe a rare case of varicella infection reactivation after routine zoster vaccination in an immunocompetent female in her 60s who developed dermatomal pruritic and vesicular rash one week after receiving Shingrix vaccine, along with fever, sweating, headache, and fatigue. The patient was treated as a case of herpes zoster reactivation with a seven days course of acyclovir. She continued to do well on follow-up with no significant complications. Though uncommon, it is important for healthcare providers to recognize this adverse reaction to expedite testing and treatment.PMID:36874700 | PMC:PMC9979095 | DOI:10.7759/cureus.34431
Source: Herpes - March 6, 2023 Category: Infectious Diseases Authors: Feras Altukhaim May Mutlaq Mohammed Alghamdi Salha Hakami Source Type: research
Post-vaccination headache reporting: Trends according to the Vaccine Adverse Events Reporting System
CONCLUSION: In a national surveillance system, headache was a commonly reported post-vaccination adverse event; a small subset of reports was considered serious. The development of standardized vaccine-related case definitions could be useful for better evaluating headache as an adverse event during vaccine development, and may reduce vaccine hesitancy especially in headache-prone individuals.PMID:36651626 | DOI:10.1111/head.14458
Source: Headache - January 18, 2023 Category: Neurology Authors: Alexandra N Cocores Peter J Goadsby Teshamae S Monteith Source Type: research
Headache After Vaccination: An Update on Recent Clinical Trials and Real-World Reporting
Curr Pain Headache Rep. 2022 Nov 23. doi: 10.1007/s11916-022-01094-y. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: The aim of this review is to characterize headache as a vaccine adverse event (VAE) in clinical trials.RECENT FINDINGS: Of the recent phase III vaccine RCTs (non-COVID-19), 53 studies reported on headache (13 infectious agents). The median rate (interquartile range) of headache was 15.6% (IQR: 9.6-37.6%). Of these, 24.5% of the RCTs reported headache greater in the vaccine group compared to the placebo/control group. In the herpes zoster vaccination trials, headache was more common in all active groups: me...
Source: Herpes - November 23, 2022 Category: Infectious Diseases Authors: Kimberly N Garces Alexandra N Cocores Peter J Goadsby Teshamae S Monteith Source Type: research
Sequential Data-Mining for Adverse Events after Recombinant Herpes Zoster Vaccination Using the Tree-Based Scan Statistic
In this study, the binomial tree-based scan statistic was applied sequentially to detect adverse events in Days 1-28 compared with Days 29-56 after recombinant herpes zoster (RZV) vaccination, with 5 looks at the data and formal adjustment for the repeated analyses over time. IBM Marketscan data on commercially insured persons 50+ years of age receiving RZV during January 1, 2018-May 5, 2020 were used. With 999,876 doses of RZV included, statistically significant signals were detected only for unspecified adverse effects/complications following immunization, with attributable risks as low as 2 excess cases per 100,000 vacc...
Source: Am J Epidemiol - October 13, 2022 Category: Epidemiology Authors: W Katherine Yih Martin Kulldorff Inna Dashevsky Judith C Maro Source Type: research
What It Really Feels Like to Have Monkeypox
Since the global monkeypox outbreak began in May 2022, more than 22,000 cases have been confirmed in countries around the world. More than 5,000 of those cases have been recorded in the U.S., with many clustered in hotspots including New York and California. The virus, which often results in a blister-like rash and spreads through close contact, has so far predominantly affected men who have sex with men.
Even as cases tick up and monkeypox gains public attention, however, it can still be difficult to find information about testing, treatment, and vaccines. Many people who fear they are at risk or infected are left to seek...
Source: TIME: Health - August 1, 2022 Category: Consumer Health News Authors: Jamie Ducharme, Angela Haupt and Jeffrey Kluger Tags: Uncategorized healthscienceclimate monkeypox Source Type: news
